Pharmafile Logo

New syndicated patient reports –

September 7, 2022 | Living with, Patient reports, Syndicated 

Living with Uterine Fibroids and Endometriosis US 2022

Living with Uterine Fibroids (UF) and Endometriosis (Endo) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports provide pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the UF and Endo patient journeys.

UF and Endo place a similar burden on women, their family and employment opportunities. Women’s health is starting to be discussed more widely, so necessary conversations are beginning to open up meaning more women are likely to seek HCP advice and treatment. The Living with UF and Endo reports have been conducted to help pharma identify how patients truly feel, perception of their current treatment options and unmet needs.

Both reports cover the US market, Living with UF (sample of 110 patients) and Living with Endo (sample of 111 patients). The methodologies consisted of 40-minute quantitative online interviews and a small sample of 40-minute qualitative telephone interviews, including patient diary tasks 1 week before the interviews.

Research Partnership has also recently launched new US reports in Living with CKD, PsA, Ankylosing Spondylitis. To find out more about these new reports or to request an information pack please contact us now.

Head of Living With, Mariel Metcalfe commented, “Research Partnership is committed to producing research which focuses on the voice of the patient, and to offer a more patient-centric view of what it is like to live with a long-term, life-changing illness. Our reports cover a wide range of therapy areas from Autoimmune, Dermatology and Gastroenterology, and we hope to expand the list of therapy areas year on year.”

Find out more about Living With here

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development

Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and...

Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot

This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a panel of 220 physicians across...

Navigating the future of AI: Insights from EphMRA’s one day meeting in London

Authored by: Ellie Forde and Mark Braund, Directors

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Autoimmune conditions: Living With syndicated patient reports

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...